• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ki-67 和 P63 的免疫组织化学表达与膀胱癌尿路上皮癌侵袭性的相关性。

Correlation between immunohistochemical expression of Ki-67and P63 and aggressiveness of urinary bladder urothelial carcinoma.

机构信息

Urology Departments, Faculty of Medicine, Menoufia University, Shebein Elkom, Egypt.

Pathology Departments, Faculty of Medicine, Menoufia University, Shebein Elkom, Egypt.

出版信息

J Immunoassay Immunochem. 2021 Mar 4;42(2):188-201. doi: 10.1080/15321819.2020.1844752. Epub 2020 Nov 18.

DOI:10.1080/15321819.2020.1844752
PMID:33206579
Abstract

Urothelial carcinoma is the most common urinary malignancy with a wide proportion of cancer morbidity and mortality. The aim of the present study is to evaluate Ki-67 and p63 immunoexpression and their correlation with grade and stage of bladder urothelial carcinoma. Fifty cases of bladder urothelial carcinoma were investigated and were submitted to immunohistochemical staining for p63 and Ki-67, which were assessed qualitatively and quantitatively. A high percentage of p63 immunoexpression showed a significant association with low-grade tumors ( < .05), while Ki-67 mean percentage of expression was higher in high-grade tumors, advanced stage and multiple tumors compared to low grade, early-stage and single tumors without statistical association. Furthermore, the mean percentage of p63 was higher in urothelial carcinoma with squamous differentiation compared to pure urothelial carcinoma with an absence of statistical significance. P63 could help in the identification of bladder tumors with squamous differentiation since identifying these cases is important regarding prognostic and therapeutic aspects. Ki 67 seems to be associated with features of bladder tumor progression as multiplicity, high grade and advanced stage.

摘要

尿路上皮癌是最常见的泌尿系统恶性肿瘤,其发病率和死亡率都很高。本研究旨在评估 Ki-67 和 p63 的免疫表达及其与膀胱尿路上皮癌分级和分期的关系。对 50 例膀胱尿路上皮癌进行了研究,并进行了 p63 和 Ki-67 的免疫组织化学染色,定性和定量评估。高比例的 p63 免疫表达与低级别肿瘤显著相关(<0.05),而 Ki-67 高表达百分比在高级别肿瘤、晚期和多发性肿瘤中高于低级别、早期和单发肿瘤,但无统计学关联。此外,与单纯尿路上皮癌相比,具有鳞化分化的尿路上皮癌中 p63 的平均百分比更高,但无统计学意义。p63 有助于识别具有鳞化分化的膀胱肿瘤,因为这些病例在预后和治疗方面很重要。Ki 67 似乎与肿瘤的多发性、高级别和晚期等进展特征有关。

相似文献

1
Correlation between immunohistochemical expression of Ki-67and P63 and aggressiveness of urinary bladder urothelial carcinoma.Ki-67 和 P63 的免疫组织化学表达与膀胱癌尿路上皮癌侵袭性的相关性。
J Immunoassay Immunochem. 2021 Mar 4;42(2):188-201. doi: 10.1080/15321819.2020.1844752. Epub 2020 Nov 18.
2
Ki-67 and Cell Cycle Regulators p53, p63 and cyclinD1 as Prognostic Markers for Recurrence/ Progression of Bladder Urothelial Carcinoma.Ki-67及细胞周期调节因子p53、p63和细胞周期蛋白D1作为膀胱尿路上皮癌复发/进展的预后标志物
Pathol Oncol Res. 2018 Apr;24(2):309-322. doi: 10.1007/s12253-017-0250-2. Epub 2017 May 9.
3
Prognostic value of Ki67 and p63 expressions in bladder cancer patients who underwent radical cystectomy.Ki67和p63表达在接受根治性膀胱切除术的膀胱癌患者中的预后价值。
Int Urol Nephrol. 2016 Apr;48(4):495-501. doi: 10.1007/s11255-015-1197-4. Epub 2016 Jan 12.
4
Expression of cell-cycle regulatory proteins and their prognostic value in superficial low-grade urothelial cell carcinoma of the bladder.细胞周期调节蛋白在膀胱浅表性低级别尿路上皮细胞癌中的表达及其预后价值
Eur J Surg Oncol. 2003 Feb;29(1):74-80. doi: 10.1053/ejso.2002.1371.
5
Role of p53 and Ki-67 immunomarkers in carcinoma of urinary bladder.p53和Ki-67免疫标志物在膀胱癌中的作用
Indian J Pathol Microbiol. 2017 Oct-Dec;60(4):505-509. doi: 10.4103/IJPM.IJPM_246_17.
6
Low-level Ki-67 expression as an independent predictor of bladder tumour recurrence in patients with primary upper tract urothelial carcinoma after radical nephroureterectomy.低水平Ki-67表达作为根治性肾输尿管切除术后原发性上尿路尿路上皮癌患者膀胱肿瘤复发的独立预测指标。
Jpn J Clin Oncol. 2015 Dec;45(12):1175-81. doi: 10.1093/jjco/hyv139. Epub 2015 Oct 8.
7
Immunohistochemical expression of p63, p53 in urinary bladder carcinoma.p63、p53在膀胱癌中的免疫组化表达。
Indian J Pathol Microbiol. 2013 Jan-Mar;56(1):10-5. doi: 10.4103/0377-4929.116141.
8
Immunohistochemical expression of p63, p53 and MIB-1 in urinary bladder carcinoma. A tissue microarray study of 158 cases.p63、p53和MIB-1在膀胱癌中的免疫组织化学表达。158例组织芯片研究
Virchows Arch. 2006 Mar;448(3):319-24. doi: 10.1007/s00428-005-0092-2. Epub 2005 Nov 8.
9
Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.CK20 和 Ki-67 免疫组化联合分析预测 pT1 尿路上皮膀胱癌的复发、进展和癌症特异性生存。
Eur Urol. 2014 Jan;65(1):218-26. doi: 10.1016/j.eururo.2012.05.033. Epub 2012 May 19.
10
[Immunohistochemical study of p53 and Ki-67 overexpression in grade 3 superficial bladder tumor in relationship to tumor recurrence and prognosis].[3级浅表性膀胱肿瘤中p53和Ki-67过表达与肿瘤复发及预后关系的免疫组织化学研究]
Nihon Hinyokika Gakkai Zasshi. 2001 Nov;92(7):656-65. doi: 10.5980/jpnjurol1989.92.656.

引用本文的文献

1
Reduced p63 expression is linked to unfavourable prognosis in muscle-invasive urothelial carcinoma of the bladder.p63表达降低与膀胱肌层浸润性尿路上皮癌的不良预后相关。
BJUI Compass. 2024 Sep 10;5(11):1081-1089. doi: 10.1002/bco2.431. eCollection 2024 Nov.
2
Prognostic Value of P63 Expression in Muscle-Invasive Bladder Cancer and Association with Molecular Subtypes-Preliminary Report.P63表达在肌层浸润性膀胱癌中的预后价值及其与分子亚型的关系——初步报告
Curr Issues Mol Biol. 2024 Mar 14;46(3):2456-2467. doi: 10.3390/cimb46030155.
3
Management of Primary Female Urethral Adenocarcinoma: Two Rare Case Reports and Literature Review.
原发性女性尿道腺癌的治疗:两例罕见病例报告及文献复习。
Medicina (Kaunas). 2023 Jan 4;59(1):109. doi: 10.3390/medicina59010109.